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Previously explored combination therapies mostly involved the use of bioactive molecules. It is believed
that herbal compounds containing multiple plant products have synergistic hepatoprotective effects and
could enhance the desired actions. To investigate the combination of ethanolic fruits extract of Solanum
xanthocarpum (SX) and Juniperus communis (JC) against Paracetamol (PCM) and Azithromycin (AZM)
induced liver toxicity in rats. Liver toxicity was induced by combine oral administration of PCM (250 mg/
kg) and AZM (200 mg/kg) for 7 days in Wistar rats. Fruit extract of SX (200 and 400 mg/kg) and JC (200
and 400 mg/kg) were administered daily for 14 days. The hepatoprotective activity was assessed using
liver functional test, oxidative parameters and histopathological examination. The results demonstrated
that combine administration of AZM and PCM signiﬁcantly produced liver toxicity by increasing the
serum level of hepatic enzymes and oxidative parameters in liver of rats. Histopathological examination
also indicated that AZM and PCM produced liver damage in rats. Chronic treatment of SX and JC extract
signiﬁcantly and dose-dependently attenuated the liver toxicity by normalizing the biochemical factors
and no gross histopathological changes were observed in liver of rats. Furthermore, combine adminis-
tration of lower dose of SX and JC signiﬁcantly potentiated their hepatoprotective effect which was
signiﬁcant as compared to their effect per se. The results clearly indicated that SX and JC extract has
hepatoprotective potential against AZM and PCM induced liver toxicity due to their synergistic anti-
oxidant properties.
Copyright © 2016, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Liver diseases are one of most serious and common disease in
worldwide but, despite tremendous advanced in modernmedicine,
their prevention and treatment options still remain limited. The
role of oxidative stress and inﬂammation is well noted in the
pathogenesis of hepatic diseases. Liver is vital organ in the body
which plays an important role in drug elimination and detoxiﬁca-
tion. Liver diseases are characterized by a progressive evolutionrsiti Teknologi MARA (UiTM),
elangor, Malaysia.
sh).
for Food and Biomolecules,
molecules, National Taiwan Unive
ons.org/licenses/by-nc-nd/4.0/).from steatosis to chronic hepatitis, ﬁbrosis, cirrhosis, and hepato-
cellular carcinoma and are associated with high morbidity and
mortality.1 The management of liver disease is still a challenge to
modern system of medicine.2 The herbal drugs are widely used in
the treatment of hepatic disorders.3 The plant extract from the
Herbal plant are now in great demand in the developing world for
primary health. It is considered to be inexpensive and safe to
recommend for the treatment of liver disorder.4
The hepatotoxicity can be produced by alcohol, chemical and
xenobiotics. Paracetamol induced toxicity in animal is one of the
most commonly experimental model to evaluate the hep-
atoprotective activity.5 At therapeutic doses paracetamol is
considered a safe for liver. However, when given at overdoses, it is
the leading cause of liver, kidney, and other organ damages in both
humans and animals.6 It is rapidly metabolized in the liver byrsity. Production and hosting by Elsevier Taiwan LLC. This is an open access article
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and also metabolized by cytochrome P450 isoenzymes to the
extremely toxic substance N-acetyl-p benzoquinoneimine
(NAPQI).7 It depletes hepatic glutathione stores in hepatic cells.8
This condition leads to the formation of reactive oxygen and ni-
trogen species, and initiates lipid peroxidation that eventually re-
sults in damage, necrosis or apoptosis of the liver cells.9
Solanum xanthocarpum Schrad. & Wendl. (Solanaceae)
commonly known as Yellow Berried Nightshade (kantakari), found
as weed throughout India. The fruits are well known for their
anthelmintic, laxative, anti-inﬂammatory, diuretic, urinary stone
and aphrodisiac activities.10 Plant is reported to have steroidal
saponin as glycoalkaloids, ﬂavonoids, sterols and phenolic tan-
nins.11 It is has been reported to have anti-inﬂammatory,12 anti-
nociceptive,13 spasmolytic,14 antioxidant,15 hepatoprotective16 and
diuretic17 activities.
Juniperus communis Linn. (Cuppressaceae) is a coniferous
shrub.18 It is widely distributed across the Himalayas from Kumaon
at an altitude of 1700e4200 m.19 Plant has been reported as a
traditional cure for chest troubles such as bronchitis10 and for
tuberculosis.20 The J. communis is reported to have anti-
inﬂammatory, anti-pyretic, analgesic and antimicrobial
activities.21e23 However there is no single report yet demonstrated
on interaction studies among S. xanthocarpum and J. communis for
potent hepatoprotective potential against additive/synergistic ef-
fect of paracetamol and azithromycin induced liver toxicity. It has
been well reported that S. xanthocarpum was found to be hep-
atoprotective by modulating only liver enzymes, which was not
sufﬁcient to provide enough protection from free radical injury.
Moreover, J. communiswas demonstrated for anti-oxidant potential
against different animal models. Therefore, combining both the
individual action for counteracting the liver pathogenesis would be
novel challenge in liver diseases. Therefore, the present study was
designed to investigate the synergistic effect of the combination of
ethanolic fruits extract of S. xanthocarpum and J. communis against
paracetamol and azithromycin induced liver toxicity in rats.
2. Material and methods
2.1. Chemicals and reagents
The plant extracts of S. xanthocarpum and Juniperus communis
were procured from the CSIR-Institute of Himalayan Bioresource
Technology (IHBT), Himachal Pradesh, India. Silymarin, Trichloro
acetic acid (TCA), Thiobarbituric acid (TBA), Ethyl-
enediaminetetraacetic acid (EDTA), were purchased from Sigma
Aldrich, co., Mumbai. The diagnostic kits for Serum glutamate
oxaloacetate transaminase (SGOT), Serum glutamate pyruvate
transaminase (SGPT), alkaline phosphatase (ALP), total protein (TP)
and total bilirubin (TB) were purchased from Calkine and coral
private Ltd. All other reagents or chemicals used were of highest
commercial analytical grade obtained from CDH and Sigma-
Aldrich, USA.
2.2. In-vivo model of paracetamol and azithromycin induced
hepatotoxicity in rats
2.2.1. Experimental animals
Wistar albino rats of either sex weighing between 180 and 220 g
were selected in the present study vide IAEC approval no ISF/
CPCSEA/IAEC/2013/121. The experiments were conducted accord-
ing to the ethical norms approved by Institutional Animal Ethics
Committee (IAEC) guide lines for animal care and were adhered to
as recommended by CPCSEA guidelines for the use and care of
experimental animals. Animals were housed in environmentallycontrolled (25 ± 2 C, 12 h light & dark cycle) small cages, with free
access to standard laboratory chow diet and water ad-libitum.
2.2.2. Experimental protocol and procedure
The animals were divided into six groups (n ¼ 6). The SX extract
(200 and 400mg/kg), JC extract (200 and 400mg/kg), and standard
drug silymarin (50 mg/kg) were administered orally for 14 days.
Liver toxicity was induced by continuous administration of PCM
(250 g/kg, p.o.) and AZM (200 mg/kg, p.o.) for 7 days from 7th day
to 14th day after 2 h after the test and standard drug
administration.24
The experimental groups can be summarized as follows:
Group 1: Normal control (Rats received 0.5% CMC for 7 days)
Group 2: Toxicant control (Rats administered with 0.5%
CMCþ toxicant PCM (250 g/kg) and AZM (200mg/kg) for 7 days
Group 3: Silymarin (Rats treated with silymarin suspension
(50 mg/kg; p.o.) for 14 days þ toxicant PCM (250 g/kg) and AZM
(200 mg/kg) for 7 days
Group 4 and 5: SX (Rats treated with SXE extract (200 and
400mg/kg; p.o.) for 14 daysþ toxicant PCM (250 g/kg) and AZM
(200 mg/kg) for 7 days
Group 6 and 7: JC (Rats treated with JCE extract (200 and
400mg/kg; p.o.) for 14 daysþ toxicant PCM (250 g/kg) and AZM
(200 mg/kg) for 7 days
Group 8: SXþ JC (Rats treatedwith SXE and JCE extract (200mg/
kg; p.o. each) for 14 days þ toxicant PCM (250 g/kg) and AZM
(200 mg/kg) for 7 days
On day 14, animals were anaesthetized by ketamine, blood was
collected, allowed to clot, and serumwas separated for assessment
of enzyme activity. The rats were then sacriﬁced by bleeding; the
livers were carefully dissected then removed and rinsed with ice-
cold isotonic saline then kept on ice and the liver was separated
and weighed. A 10% (w/v) tissue homogenates were prepared in
0.1 M phosphate buffer (pH 7.4). The homogenates were centri-
fuged at 10,000 g for 15 min and aliquots of the supernatants
were separated and used for tissue biochemical estimation. Some
part of the liver tissue was immediately transferred into 10%
formalin for histopathological investigation.
2.3. Estimation of serum biochemical parameters
Biochemical parameters like serum glutamate oxaloacetate
transaminase (SGOT), Serum glutamate pyruvate transaminase
(SGPT), alkaline phosphatase (ALP) and Total bilirubin (TB) were
estimated using commercial enzymatic biochemical diagnostic kits
according to manufacturer's instructions.
2.4. Estimation of tissue biochemical parameters
2.4.1. Measurement of lipid per oxidation
The extent of lipid per oxidation in the liver was determined
quantitatively by performing the method as described by
Ohkawa.25 The amount of malondialdehyde (MDA) was
measured by reaction with thiobarbituric acid at 532 nm using
Schimadzu spectrophotometer (Japan). The values were calcu-
lated using the molar extinction co-efﬁcient of chromophore
(1.56  105 M1 cm1) and expressed as percentage of control.
2.4.2. Estimation of nitrite
The accumulation of nitrite in the supernatant, an indicator of
the production of nitric oxide was determined by a colorimetric
assay with Greiss reagent (0.1% N-(1-napththyl) ethylene diamine
dihydrochloride, 1% sulphanilamide and 5% phosphoric acid). Equal
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the mixture was incubated for 10 min at room temperature in the
dark. The absorbance was measured at 540 nm using Schimadzu
spectrophotometer (Japan). The concentration of nitrite in the su-
pernatant was determined from sodium nitrite standard curve26
and expressed as percentage of control.2.4.3. Estimation of reduced glutathione levels
Reduced glutathione was estimated according to the method
described by Ellman.27 1 ml supernatant was precipitated with 1ml
of 4% sulphosalicylic acid and cold digested for 1 h at 48 C. The
samples were then centrifuged at 1200g for 15min at 4 C. To 1ml
of the supernatant obtained, 2.7 ml of phosphate buffer (0.1 mmol/
l, pH 8) and 0.2 ml of 5,50dithio-bis (2-nitrobenzoic acid) (DTNB)
was added. The yellow color developed was measured at 412 nm
using Schimadzu spectrophotometer (Japan). Results were calcu-
lated using molar extinction co-efﬁcient of the chromophore
(1.36  104 (mol/l)1cm1) and expressed as percentage of control.2.4.4. Catalase estimation
Brieﬂy, the assay mixture consisted of 12.5 mM H2O2 in phos-
phate buffer (50mM of pH 7.0) and 0.05ml of supernatant from the
tissue homogenate (10%) and the change in absorbance was
recorded at 240 nm. The results were expressed as mM of H2O2
decomposed per milligram of protein/min.282.4.5. Protein estimation
The protein content was estimated by Biuret method29 using
bovine serum albumin as a standard.2.4.6. Histopathological studies
Liver tissues were ﬁxed in 10% formalin for at least 24 h,
embedded in parafﬁn, and cut into 5 mm-thick sections using a
rotary microtome. The sections were stained with Hematoxylin-
eosin dye and observed under a microscope (IX51, Olympus, Japan)
to observe histopathological changes in the liver.2.5. Statistical analysis
All experiments were done in triplicate and results were re-
ported as mean ± S.E.M. (n ¼ 6). The data were analyzed by one-
way ANOVA, and statistically signiﬁcant effects were further
analyzed by means comparison using Tukey's multiple comparison
analysis. The p < 0.05 was considered to be statistically signiﬁcant.3. Results
3.1. Effect of ethanolic extract of S. xanthocarpum and Juniperus
communis fruits extract on liver enzymes against AZM and PCM
induced liver toxicity in rats
Oral combine administration of AZM and PCM signiﬁcantly
increased the levels of liver enzymes (SGPT, SGOT and ALP) as
compared to the sham control treated group. Ethanolic extract of
SX (200 and 400 mg/kg) and JC (200 and 400 mg/kg) treatments
signiﬁcantly attenuated the liver enzymes (SGPT, SGOT and ALP) in
AZM and PCM treated animals. Moreover, combine treatment of
sub therapeutic dose of Ethanolic extract of SX and JC signiﬁcantly
potentiated the hepatoprotective effect which was signiﬁcant to
their individual effects, suggesting hepatoprotective potential
(Table 1).3.2. Effect of S. xanthocarpum and Juniperus communis on
bilirubin, protein and albumin levels against AZM and PCM induced
toxicity in rats
Chronic administration of PCM signiﬁcantly impaired in the
activity of Bilirubin, Protein and Albumin as compared to the sham
control treated group. Extract of SX (200 and 400 mg/kg) and JC
(200 and 400 mg/kg) treatments signiﬁcantly restored bilirubin,
protein and albumin in PCM treated animals. Additionally, combi-
nation treatment of sub therapeutic dose of Extract of SX and JC
signiﬁcantly potentiated the hepatoprotective effect which was
signiﬁcant to their individual effects, suggesting hepatoprotective
potential (Table 2).
3.3. Effect of S. xanthocarpum and Juniperus communis on
oxidative stress parameters in AZM and PCM treated rats
Chronic treatment with PCM (3 g/kg, p.o.) for 7 days showed
signiﬁcant increase oxidative damage indicating increase of lipid
peroxidation and nitrite concentration in the liver of the rat as
compare to control group. However, co-administration of extract of
SX extract (200 and 400mg/kg) and JC extract (200 and 400mg/kg)
alone signiﬁcantly attenuated the increased level of the lipid per-
oxidation and nitrite concentration of PCM treated rats dose
dependently. Further, low dose combination of SX and JC extract
signiﬁcantly potentiate their anti-oxidant effect as compare to their
effect per se respectively (Figs. 1 and 2).
3.4. Effect of ethanolic extract of S. xanthocarpum and Juniperus
communis on catalase and reduced glutatione against AZM and
PCM induced toxicity in rats
Administration of Paracetamol signiﬁcantly reduced GSH and
catalase enzyme activity in the liver as compared with the sham
control treated group respectively (Fig.3). Extract of SX (200 and
400 mg/kg) and JC (200 and 400 mg/kg) treatments signiﬁcantly
restored endogenous antioxidant enzymes (reduced GSH and
catalase) activities as compared with diseased treated animals.
Furthermore, low dose combination of SX with JC signiﬁcantly
potentiated their protective effect (antioxidant like effect) as
compared to their individual effect produced at higher doses
(Figs. 3 and 4).
3.5. Histopathological observations
The different groups of rats were studied for cellular architec-
ture of the liver tissue by histopathological analysis which is pre-
sented in Fig. 5(AeH). The photomicrograph of the liver of rat
showed normal architecture of hepatic cells with clear cytoplasm
and slightly dilated central veins, normal kupffer cells and all cells
had normal large nuclei (Fig. 5A). The liver tissue showed distorted
architecture with broad area of necrosis in AZM and PCM control
group (Fig. 5B). The silymarin group-3 also showed less inﬂam-
mation and no necrosis in liver cells (Fig. 5C). The animal group 4e8
pretreatment with the SX and JC extracts (100 and 200 mg/kg) and
combination of both extract (200 mg/kg; p.o. each), showed the
more of normal architecture of the liver tissue with minimum
inﬂammation (Fig. 5DeH). The induction of hepatotoxicity by AZM
along with PCM and hepatoprotective effect of SX and JC extract is
also supported by histological observations.
4. Discussion
In the present study, we demonstrated that SX and JC play an
important role in drugs induced liver damage. In the assessment of
Table 2
Effect of Solanum xanthocarpum and Juniperus communis on bilirubin, protein and albumin on serum against PCM and AZM induced toxicity in rats.
Groups Bilirubin (mg/dl) Protein (gm/dl) Albumin (gm/dl)
Normal (Control) 0.7 ± 0.09 6.425 ± 0.08 3.975 ± 0.1
PCM (250) þ AZM (200) 1.0475 ± 0.007a 3.95 ± 0.3a 3.725 ± 0.2a
PCM (250) þ AZM (200) þ Silymarin (50) 0.615 ± 0.06 6.725 ± 0.2 3.95 ± 0.2
PCM (250) þ AZM (200) þ SXE (200) 0.7125 ± 0.01b 5.675 ± 0.1b 3.775 ± 0.3b
PCM (250) þ AZM (200) þ SXE (400) 0.4 ± 0.04b,c 6.6 ± 0.2b,c 4.375 ± 0.08b,c
PCM (250) þ AZM (200) þ JCE (200) 0.7625 ± 0.02b 6.15 ± 0.3b 3.45 ± 0.1b
PCM (250) þ AZM (200) þ JC (400) 0.4975 ± 0.03b,d 5.675 ± 0.2b,d 4 ± 0.1b,d
PCM (250) þ AZM (200) þ SX (200) þ JC (200) 0.3975 ± 0.01c,d 6.3 ± 0.09c,d 4.1 ± 0.3c,d
Values are expressed asmean ± SEM n¼ 6. aP < 0.05 vs Normal control; bP < 0.05 vs PCMþ AZM; cP < 0.05 vs (PCMþ AZM)þSX (200); dP < 0.05 vs (PCMþ AZM)þJ.C. (200) SX:
Solanum xanthocarpum; JC: Juniperus communis; PCM: Paracetamol; AZM: Azithromycin.
Table 1
Effect of Solanum xanthocarpum and Juniperus communis on liver enzymes on serum against PCM and AZM induced rats.
Groups SGPT(IU/l) SGOT(IU/l) ALP (IU/l)
Normal (Control) 30.5 ± 1.5 32 ± 1.2 145.25 ± 1.49
PCM (250) þ AZM (200) 106.75 ± 6.9a 195 ± 7.5a 428.5 ± 60.0a
PCM (250) þ AZM (200) þ Silymarin (50) 43.75 ± 3.7 57.25 ± 3.7 147.75 ± 2.2
PCM (250) þ AZM (200) þ SXE (200) 61.25 ± 2.3b 142.25 ± 10.3b 155.5 ± 3.6b
PCM (250) þ AZM (200) þ SXE (400) 58.5 ± 4.2b,c 70.75 ± 4.8b,c 146.25 ± 1.6b,c
PCM (250) þ AZM (200) þ JCE (200) 89.5 ± 7.7b 181.25 ± 9.03b 214 ± 29.7b
PCM (250) þ AZM (200) þ JC (400) 172.9 ± 1.4b,d 127.75 ± 11.3b,d 149.5 ± 3.4b,d
PCM (250) þ AZM (200) þ SX (200) þ JC (200) 43.5 ± 1.3 67.5 ± 5.4c 142.25 ± 2.01c
Values are expressed asmean ± SEM n¼ 6. aP < 0.05 vs Normal control; bP < 0.05 vs PCMþ AZM; cP < 0.05 vs (PCMþ AZM)þSX (200); dP < 0.05 vs (PCMþ AZM)þJ.C. (200) SX:
Solanum xanthocarpum; JC: Juniperus communis; PCM: Paracetamol; AZM: Azithromycin.
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ALT and AST in serum should be determined. These enzymes are
very sensitive markers employed in the diagnosis of liver
diseases.30
Nonsteroidal anti-inﬂammatory drugs and antibiotics are
considered the most common medications associated with drug-
induced liver injury mainly through an idiosyncratic form of hep-
atotoxicity. PCM-induced liver hepatotoxicity as an experimental
model of drug-induced acute hepatic necrosis is well established.
PCM induced hepatocellular injury and death involves its conver-
sion to a toxic highly reactive metabolite, N-acetyl-para-benzo-
quinonimine (NAPQI). Generally, PCM is primarily metabolized via
cytochrome P-450 to form the highly electrophilic NAPQI which is
eliminated by conjugation with glutathione (GSH) and furtherFig. 1. Effect of SX and JC on LPO against PCM and AZM induced toxicity in rats. Values
are expressed as mean ± SEM n ¼ 6. aP < 0.05 vs Normal control; bP < 0.05 vs
PCM þ AZM; cP < 0.05 vs (PCM þ AZM)þS.X. (200); dP < 0.05 vs (PCM þ AZM)þJ.C.
(200) SX: Solanum xanthocarpum; JC: Juniperus communis; PCM: Paracetamol; AZM:
Azithromycin.metabolized to a mercapturic acid which is excreted through the
urine.31
The mode of action of paracetamol on the liver is by covalent
binding of its toxic metabolite, n-acetyl-p-benzoquinone-amine to
the sulfhydryl group of protein resulting in cell necrosis and lipid
peroxidation.32 Due to liver injury caused by paracetamol overdose,
the transport function of the hepatocytes gets disturbed resulting
in the leakage of the plasma membrane,33 thus causing an increase
in serum enzyme levels.
Recently, Antibiotic-associated hepatotoxicity is another chal-
lenge for liver disease. Azithromycin has been linked to two forms
of hepatotoxicity. The ﬁrst is an acute, transient and asymptomatic
elevation in serum aminotransferases which occurs in 1e2% of
patients treated for short periods and a somewhat higher propor-
tion of patients are given azithromycin for long-term.Fig. 2. Effect of SX and JC on nitrite against PCM and AZM induced toxicity in rats.
Values are expressed as mean ± SEM n ¼ 6. aP < 0.05 vs Normal control; bP < 0.05 vs
PCM þ AZM; cP < 0.05 vs (PCM þ AZM)þS.X. (200); dP < 0.05 vs (PCM þ AZM)þJ.C.
(200) SX: Solanum xanthocarpum; JC: Juniperus communis; PCM: Paracetamol; AZM:
Azithromycin.
Fig. 3. Effect of SX and JC on catalase against PCM and AZM induced toxicity in rats.
Values are expressed as mean ± SEM n ¼ 6. aP < 0.05 vs Normal control; bP < 0.05 vs
PCM þ AZM; cP < 0.05 vs (PCM þ AZM)þS.X. (200); dP < 0.05 vs (PCM þ AZM)þJ.C.
(200) SX: Solanum xanthocarpum; JC: Juniperus communis; PCM: Paracetamol; AZM:
Azithromycin.
Fig. 4. Effect of SX and JC on reduced glutathione against PCM and AZM induced
toxicity in rats. Values are expressed as mean ± SEM n ¼ 6. aP < 0.05 vs Normal control;
bP < 0.05 vs PCM þ AZM; cP < 0.05 vs (PCM þ AZM)þS.X. (200); dP < 0.05 vs
(PCM þ AZM)þJ.C. (200) SX: Solanum xanthocarpum; JC: Juniperus communis; PCM:
Paracetamol; AZM: Azithromycin.
Fig. 5. Effects of SX and JC on histopathological changes induced by PCM and AZM in rats. (
animals treated with PCM (250 mg/kg) and AZM (200 mg/kg) and silymarin (50 mg/kg), (D
400 mg/kg), (Fand G) animals treated with PCM (250 mg/kg) and AZM (200 mg/kg) and JC (
and SX (200 mg/kg) and JC (200 mg/kg). All sections were stained with Hematoxylin/eosin
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caused signiﬁcant increase of liver enzymes like SGPT, SGOT, ALP,
bilirubin and albumin in serum of rats which is attributed to the
liver dysfunction. These results are in consistent with previous
reports for drug induced liver toxicity.34 Though the complete
mechanism action of PCM induced liver injury is well demon-
strated, however, AZM associated toxicity are still unclear. AZM
was reported to cause cholestatic as an adverse effect. However,
it is also well known that cholestasis with hepatitis is a common
feature of macrolide hepatotoxicity.35,36 Marcolides is known to
induce its own biotransformation by enhancing microsomal
enzymes in the liver with high afﬁnity to AZM. Azithromycin has
a long half-life and it has been demonstrated that the protein
concentration of AZM is high in liver due to its long half life.37
Our results also revealed that combine administration of AZM
and PCM for 7 days signiﬁcantly increased the oxidative damage
indicating the increased level of MDA and nitrite concentration
and decreased the activity of endogenous anti-oxidant like
reduced glutathione and catalase in liver homogenate of rats.
Many common diseases are caused by marked oxidative stress in
cellular proteins. Oxidative stress is another possible marker of
liver disease. Liver injury is involved in to production of ROS
which can cause abstraction of a hydrogen atom from an un-
saturated lipid and initiating lipid peroxidation. Peroxidation of
lipids results in considerable changes in membrane structure
and cause DNA damage, cytotoxicity and cell death.38 MDA was a
biomarker to measure the level of oxidative stress in organ-
isms.39 In the present study, MDA level has markedly increased
in toxicant group in comparison with the normal control group.
This condition is closely related to paracetamol-induced lipid
peroxidation and damage to plasma membrane because of
oxidative stress. Endogenous antioxidants play a key role in
protecting liver against different toxicant.40 GSH is an endoge-
nous antioxidant enzyme which protecting against liver injury. It
plays a key role in detoxiﬁcation of the acetaminophen metab-
olite, NAPQI. Moreover it scavenges reactive oxygen species.41
The reduction in SOD and CAT activity in drug exposed ani-
mals may be due to the overproduction of superoxide radical
anions.42
Liver histopathology slides show vacuolated cytoplasm with
pyknotic nuclei and evidence of hepatocellular damage in AZM and
PCM treated rats. However, pretreatment with SX extract (200 and
400 mg/kg) groups signiﬁcantly decreased MDA level.A) Control group, (B) animals treated with PCM (250 mg/kg) and AZM (200 mg/kg) (C)
and E) animals treated with PCM (250 mg/kg) and AZM (200 mg/kg) and SX (200 and
200 and 400 mg/kg), (H) animals treated with PCM (250 mg/kg) and AZM (200 mg/kg)
; 40X for all panels except (B), (D) and (H) which were 100X magniﬁcation.
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kg for 7 days resulted in a signiﬁcant (p < 0.05) reduction of
paracetamol induced elevation of serum enzyme markers, com-
parable to the effect of silymarin as the positive control. Silymarin is
a known hepatoprotective compound. It is reported to have a
protective effect on plasma membrane of hepatocytes.43
The liver enzyme marker such as SGOT (serum glutamic oxa-
loacetic transaminase) and SGPT (serum glutamic pyruvic trans-
aminase) have still remained the standard for the assessment of
liver toxicity, and have been used as biomarkers of choice for de-
cades.44 Tests of liver function may therefore prove useful in
assessing especially the toxic effects of drugs on the liver. These
parameters for the determination of SGOT and SGPT. The liver cell
necrosis leads to a signiﬁcant rise of these enzymes in the blood
serum. Hence, SOD and CAT enzyme activity in liver was signiﬁ-
cantly lower in the toxicant group. However, the SOD and CAT
enzyme activity in doses (200 and 400 mg/kg) of the pretreated
groups signiﬁcantly increased when compared with the toxicant
group.
In the present study, the SX extract appears to be efﬁcient in
reducing the AZM and PCM induced injury as observed from a
signiﬁcant reduction of AZM and PCM induced elevated serum
enzyme levels. It was also noted that the histopathological cell
injury was improved in rat liver treated with SX extract. This im-
plies that concomitant administration of SX extract prevented
hepato necrotic changes. Hepatoprotective effect of SX extract was
further conﬁrmed by histopathological studies of the liver, which
basically supported the results from the serum parameter. Histo-
pathological studies of the liver showed fatty changes, swelling and
necrosis with loss of hepatocytes in paracetamol treated rats. SX
treated groups showed regeneration of hepatocytes, normalization
of fatty changes and necrosis of the liver. The maximum protection
against hepatic damage was achieved with the SX extract at a dose
of 400mg/kg. The histopathological investigation of the liver of rats
treated with SX extract showed a more or less normal architecture
of the liver having reversed to a large extent, the hepatic lesions
produced by paracetamol, almost comparable to the normal control
groups.
5. Conclusion
In conclusion, the present study has demonstrated that the SX
extract has shown the potent hepatoprotective activity as
compared to JC extract against paracetamol-induced hepatotoxicity
in rats and on the basis phytochemical data the plant has reported
to have the phenolic compound and ﬂavonoid. The hep-
atoprotective potential may be due to their anti-oxidant potential.
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